CHEMED CORP CHE
CHEMED CORP (CHE) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.52% (safety: safe). FY2025 revenue was $2.5B at a 10.5% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -2.76 — low (below −2.22 — no manipulation red flag) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
Analyst price target
Recent analyst actions
| Date | Firm | Rating |
|---|---|---|
| 2026-04-27 | RBC Capital | Sector Perform (main) |
| 2026-02-27 | RBC Capital | Sector Perform (down) |
| 2026-02-27 | Oppenheimer | Outperform (main) |
| 2026-01-22 | Jefferies | Hold (down) |
| 2025-11-10 | RBC Capital | Outperform (main) |
| 2025-09-10 | B of A Securities | Buy (main) |
Wall Street analyst consensus — a sentiment gauge, not our scoring.
Smart money · insiders, last 12 months
Open-market insider purchases minus sells (SEC Form 4) — real buying with their own money is a bullish “smart money” signal; grants and option exercises are excluded.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.01 |
| Retained earnings / assets | 1.921 |
| EBIT / assets | 0.22 |
| Equity / liabilities | 1.753 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CHE | CHEMED CORP | 5/9 | 9.65 | 23.2 | +4.1% |
| AVAH | Aveanna Healthcare Holdings, Inc. | 6/9 | -0.46 | 8.4 | +20.2% |
| AHCO | AdaptHealth Corp. | 5/9 | 0.26 | — | -0.5% |
| ADUS | Addus HomeCare Corp | 7/9 | 5.5 | 18.9 | +23.2% |
| EDGM | Edgemode, Inc. | 3/9 | — | — | — |
| OPCH | Option Care Health, Inc. | 5/9 | 2.97 | 16.5 | +13% |
| BTSG | BrightSpring Health Services, Inc. | 7/9 | 1.78 | 71 | +28.2% |
About CHEMED CORP
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
FAQ
Is CHE financially healthy?
CHEMED CORP's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does CHE pay a dividend, and is it safe?
Yes. CHEMED CORP pays a dividend yielding about 0.52% with a 11.9% payout ratio, rated “safe” for safety.
How profitable is CHE?
In FY2025, CHEMED CORP had a net margin of 10.5% and a return on equity of 27.1%.
Is CHE overvalued or undervalued?
CHEMED CORP trades at about 29.5× trailing earnings — near its 10-year norm (10-year range 23.3×–44.5×, median 28.3×). Stocktoria reports the data, not buy/sell advice.
What is the analyst price target for CHE?
The average Wall-Street price target for CHEMED CORP is $446.50, about 17.5% below the recent price, from 4 analysts (consensus: buy).
Is CHE a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on CHEMED CORP: a Piotroski F-score of 5/9, an Altman Z″ in the safe zone, a P/E of about 23.2×, a dividend yield of 0.52%. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.